Home > Education Hub > Reduce Time to Market with Pre-IND Meetings

Reduce Time to Market with Pre-IND Meetings

Publications

Category:

Regulatory

Published on:

November 1, 2020

Written by:

Prasanna Palle

pre-ind-graphic

Did you know reducing time to market is one of the biggest challenges companies face when seeking FDA approval on their drug development plans and clinical trials?

Prasanna Palle, Senior Associate Regulatory Consultant offers tips to reduce time to market with Pre-IND Meetings.

For more information about Alira Health’s Regulatory Services

Click here

Related news

Publications August 1, 2023

The EU Pharmaceutical Package: Impact on Orphan Medicinal Products

This article reviews the proposed changes in the EU Pharma Package for data protection related to orphan medicinal products (OMPs).

EU Pharma Regulatory

Publications July 10, 2023

The EU Pharmaceutical Package: Regulatory Protection Changes

Our regulatory experts present a more detailed analysis of the proposed changes introduced to Regulatory Data Protection (RDP).

EU Pharma Regulatory

Publications June 14, 2023

Medical Device Regulation: A Checklist for Preparation

This checklist can provide you with insight into where you stand in regards to MDR preparation and what you still need to address.

Medical Devices Regulatory

Publications May 25, 2023

The EU Pharmaceutical Package: Introduction to Changes

Alira Health’s Regulatory experts explore how the proposed package will disrupt the European regulatory landscape and what it means for companies.

EU Pharma Regulatory

News February 21, 2023

Access and reimbursement pathways for digital health solutions and IVD devices

Digital therapeutics (DTx) are innovative solutions that use meaningful data to provide evidence-based decisions for the prevention, treatment, and management of diseases. Particular(...)

Diagnostics Digital Therapeutics Market Access Regulatory Research and Development

Events February 10, 2023

Regulatory Roundup

We are pleased to announce that we are joining Regulatory Roundup as sponsors and speakers. This unique event is hosted by MassMEDIC, the largest regional medtech association in the United States.

Blog January 19, 2023

Medical Device Regulation in 2023: A Window of Opportunity

We spoke with our team of regulatory experts about the recent news regarding the MDR and the opportunity it presents to device manufacturers in 2023.

Medical Devices MedTech Regulatory